Search

Author/Creator Rodbard, H. W.

1. A comparison of adding liraglutide versus a single daily dose of insulin aspart to insulin degludec in subjects with type 2 diabetes (BEGIN: VICTOZA ADD‐ON). Issue 7 (11th February 2014)

Authors:
Mathieu, C.; Rodbard, H. W.; Cariou, B.; Handelsman, Y.; Philis‐Tsimikas, A.; Ocampo Francisco, A. M.; Rana, A.; Zinman, B.; on behalf of the BEGIN: VICTOZA ADD‐ON (NN1250‐3948) study group
Journal:
Diabetes, obesity & metabolism
Issue:
Volume 16:Issue 7(2014:Jul.)
Page Start:
636
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Comparison of insulin degludec with insulin glargine in insulin‐naive subjects with Type 2 diabetes: a 2‐year randomized, treat‐to‐target trial. Issue 11 (30th September 2013)

Authors:
Rodbard, H. W.; Cariou, B.; Zinman, B.; Handelsman, Y.; Philis‐Tsimikas, A.; Skjøth, T. V.; Rana, A.; Mathieu, C.
Journal:
Diabetic medicine
Issue:
Volume 30:Issue 11(2013:Nov.)
Page Start:
1298
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Efficacy and safety of liraglutide versus placebo added to basal insulin analogues (with or without metformin) in patients with type 2 diabetes: a randomized, placebo‐controlled trial. Issue 11 (10th September 2015)

Authors:
Ahmann, A.; Rodbard, H. W.; Rosenstock, J.; Lahtela, J. T.; de Loredo, L.; Tornøe, K.; Boopalan, A.; Nauck, M. A.; on behalf of the NN2211‐3917 Study Group
Journal:
Diabetes, obesity & metabolism
Issue:
Volume 17:Issue 11(2015:Nov.)
Page Start:
1056
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. One‐year efficacy and safety of a fixed combination of insulin degludec and liraglutide in patients with type 2 diabetes: results of a 26‐week extension to a 26‐week main trial. Issue 10 (1st July 2015)

Authors:
Gough, S. C. L.; Bode, B. W.; Woo, V. C.; Rodbard, H. W.; Linjawi, S.; Zacho, M.; Reiter, P. D.; Buse, J. B.
Journal:
Diabetes, obesity & metabolism
Issue:
Volume 17:Issue 10(2015:Oct.)
Page Start:
965
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Options for prandial glucose management in type 2 diabetes patients using basal insulin: addition of a short‐acting GLP‐1 analogue versus progression to basal‐bolus therapy. Issue 3 (20th June 2013)

Authors:
Hirsch, I. B.; Buse, J. B.; Leahy, J.; McGill, J. B.; Peters, A.; Rodbard, H. W.; Rubin, R. R.; Skyler, J. S.; Verderese, C. A.; Riddle, M. C.
Journal:
Diabetes, obesity & metabolism
Issue:
Volume 16:Issue 3(2014:Mar.)
Page Start:
206
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Safety and efficacy of insulin degludec/liraglutide (IDegLira) added to sulphonylurea alone or to sulphonylurea and metformin in insulin‐naïve people with Type 2 diabetes: the DUAL IV trial. Issue 2 (7th October 2016)

Authors:
Rodbard, H. W.; Bode, B. W.; Harris, S. B.; Rose, L.; Lehmann, L.; Jarlov, H.; Thurman, J.
Journal:
Diabetic medicine
Issue:
Volume 34:Issue 2(2017)
Page Start:
189
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Treatment intensification with an insulin degludec (IDeg)/insulin aspart (IAsp) co‐formulation twice daily compared with basal IDeg and prandial IAsp in type 2 diabetes: a randomized, controlled phase III trial. Issue 3 (11th January 2016)

Authors:
Rodbard, H. W.; Cariou, B.; Pieber, T. R.; Endahl, L. A.; Zacho, J.; Cooper, J. G.
Journal:
Diabetes, obesity & metabolism
Issue:
Volume 18:Issue 3(2016)
Page Start:
274
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗